Novel Antibody Therapeutics Congress
Website http://www.global-engage.com/event/novel-antiobody-congress/?utm_source=Directory&utm_campaign=RnT%2 |
Edit Freely
Category Oncology; antibodies; immuno-oncology; biotherapeutics
Deadline: October 04, 2019 | Date: October 10, 2019-October 11, 2019
Venue/Country: London Heathrow Marriott Hotel, U.K.
Updated: 2018-12-04 21:35:59 (GMT+9)
Call For Papers - CFP
Designed for experts in pharma and academia, this conference will explore the latest advances in antibody-based therapeutics in oncology. Talks will review the recent developments in bispecific antibody technology, as well as exploring the potential of new antibody and antibody-mimicking formats. A dedicated checkpoint blockades session will also examine new approaches in neutralizing cancer cell immune blockades, including advances in PD1, PD-L1 and CTLA4 targeting therapeutics, and the discovery and targeting of new biomarkersWith recent breakthroughs in immunotherapeutics, biotherapeutics are set to lead the way in oncology in the coming years. As one of the dominant biologic formats, monoclonal antibodies stand ready to capitalise on this, building on two decades offered of exciting advancements in the treatment of cancer.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.